DSS acquired Impact BioMedical Inc., extending its global equity interest. Jason Grady is the CEO of DSS, Inc.
1 report, 0 independent
Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
DSS acquired Impact BioMedical Inc., extending its global equity interest. Jason Grady is the CEO of DSS, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biomedical
area of research
Nothing else this week.
-
Defense Counterintelligence and Security Agency
agency in the U.S. Department of Defense
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet